With activist investment rising, Pfizer’s battle with Starboard reflects the industry’s post-pandemic tumble

From Southwest Airlines to Disney and JetBlue, activist investors have been increasingly willing to attempt a corporate coup. Pharma giants are also feeling the squeeze. Pfizer this month has been fending off the hedge fund Starboard Value, which took a $1 billion stake in the company during its post-pandemic slump.